Warning: The NCBI web site requires JavaScript to function. more...
Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity.
Toussirot E, Saas P, Deschamps M, Pouthier F, Perrot L, Perruche S, Chabod J, Tiberghien P, Wendling D.
Arthritis Res Ther. 2009;11(4):R101. Epub 2009 Jul 1.
Related citations
Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
Baeten D, Møller HJ, Delanghe J, Veys EM, Moestrup SK, De Keyser F.
Arthritis Rheum. 2004 May;50(5):1611-23.
Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis.
Gu M, Kakoulidou M, Giscombe R, Pirskanen R, Lefvert AK, Klareskog L, Wang X.
Clin Immunol. 2008 Sep;128(3):374-81. Epub 2008 Jul 2.
Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation.
Saverino D, Brizzolara R, Simone R, Chiappori A, Milintenda-Floriani F, Pesce G, Bagnasco M.
Clin Immunol. 2007 May;123(2):190-8. Epub 2007 Feb 23.
Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L, Vandooren B, Kruithof E, De Keyser F, Veys EM, Baeten D.
Arthritis Rheum. 2005 Jul;52(7):2146-58.
Expression of full-length and splice forms of FoxP3 in rheumatoid arthritis.
Ryder LR, Woetmann A, Madsen HO, Ødum N, Ryder LP, Bliddal H, Danneskiold-Samsøe B, Ribel-Madsen S, Bartels EM.
Scand J Rheumatol. 2010 Aug;39(4):279-86.
Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
Daroszewski J, Pawlak E, Karabon L, Frydecka I, Jonkisz A, Slowik M, Bolanowski M.
Eur J Endocrinol. 2009 Nov;161(5):787-93. Epub 2009 Sep 4.
The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH.
Eur J Clin Invest. 2007 Dec;37(12):987-96.
Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK, Lit LC, Tam LS, Li EK, Lam CW.
Rheumatology (Oxford). 2005 Aug;44(8):989-94. Epub 2005 May 3.
Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma.
Wong CK, Lun SW, Ko FW, Ip WK, Hui DS, Lam CW.
Clin Exp Immunol. 2005 Jul;141(1):122-9.
Regulatory cells, cytokine pattern and clinical risk factors for asthma in infants and young children with recurrent wheeze.
Borrego LM, Arroz MJ, Videira P, Martins C, Guimarães H, Nunes G, Papoila AL, Trindade H.
Clin Exp Allergy. 2009 Aug;39(8):1160-9. Epub 2009 Apr 28.
How and when to pick up the best signals from markers associated with T-regulatory cells?
Kivling A, Nilsson L, Faresjö M.
J Immunol Methods. 2009 Jun 30;345(1-2):29-39. Epub 2009 Mar 30.
A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury.
Simone R, Brizzolara R, Chiappori A, Milintenda-Floriani F, Natale C, Greco L, Schiavo M, Bagnasco M, Pesce G, Saverino D.
Int Immunol. 2009 Sep;21(9):1037-45. Epub 2009 Jul 22.
Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis.
Berner B, Wolf G, Hummel KM, Müller GA, Reuss-Borst MA.
Ann Rheum Dis. 2000 Mar;59(3):190-5.
New insights of CTLA-4 into its biological function in breast cancer.
Mao H, Zhang L, Yang Y, Zuo W, Bi Y, Gao W, Deng B, Sun J, Shao Q, Qu X.
Curr Cancer Drug Targets. 2010 Nov;10(7):728-36.
Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection.
Ayukawa H, Matsubara T, Kaneko M, Hasegawa M, Ichiyama T, Furukawa S.
Clin Exp Immunol. 2004 Jul;137(1):151-5.
Adult T-cell leukemia/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells.
Shimauchi T, Kabashima K, Tokura Y.
Cancer Sci. 2008 Jan;99(1):98-106. Epub 2007 Oct 25.
The soluble CTLA-4 receptor: a new marker in autoimmune diseases.
Pawlak E, Kochanowska IE, Frydecka I, Kiełbiński M, Potoczek S, Bilińska M.
Arch Immunol Ther Exp (Warsz). 2005 Jul-Aug;53(4):336-41. Review.
Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
Sato S, Fujimoto M, Hasegawa M, Komura K, Yanaba K, Hayakawa I, Matsushita T, Takehara K.
Rheumatology (Oxford). 2004 Oct;43(10):1261-6. Epub 2004 Jul 20.
Insulin treatment in patients with type 1 diabetes induces upregulation of regulatory T-cell markers in peripheral blood mononuclear cells stimulated with insulin in vitro.
Tiittanen M, Huupponen JT, Knip M, Vaarala O.
Diabetes. 2006 Dec;55(12):3446-54.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on